Adjuvant chemotherapy for stage III colon cancer: relative dose intensity and survival among veterans

BACKGROUND: Given the paucity of information on dose intensity, the objective of this study is to describe the use of adjuvant chemotherapy for stage III colon cancer, focusing on relative dose intensity (RDI), overall survival (OS) and disease-free survival (DFS). METHODS: Retrospective cohort of 3...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:BMC Cancer
Egile Nagusiak: Aspinall, Sherrie L, Good, Chester B, Zhao, Xinhua, Cunningham, Francesca E, Heron, Bernadette B, Geraci, Mark, Passero, Vida, Stone, Roslyn A, Smith, Kenneth J, Rogers, Renee, Shields, Jenna, Sartore, Megan, Boyle, D Patrick, Giberti, Sherry, Szymanski, John, Smith, Doug, Ha, Allen, Sessions, Jolynn, Depcinski, Shawn, Fishco, Shane, Molina, Irvin, Lepir, Tanja, Jean, Carmela, Cruz-Diaz, Lymaris, Motta, Jessica, Calderon-Vargas, Rebeca, Maland, Janelle, Keefe, Sean, Tague, Marshall, Leone, Alice, Glovack, Brian, Kaplan, Blair, Cosgriff, Sean, Kaster, Lindsay, Tonnu-Mihara, Ivy, Nguyen, Kimmai, Carmichael, Jenna, Clifford, Linda, Lu, Kan, Chatta, Gurkamal
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2015
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4352567/
https://ncbi.nlm.nih.gov/pubmed/25884851
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1038-y
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak